Index of artpub/2022/pmc_9535465/

Salvador Bofill, Javier
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer : Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
2022
https://ddd.uab.cat/record/281802